February 15, 2019 · Leave a Comment
Mayo Clinic Researchers Develop More Efficient System to Reprogram Stem Cells
Induced pluripotent stem cells, the workhorse of many regenerative medicine projects, start out as differentiated cells that are reprogrammed to pluripotent stem cells by exposure to a complex set of genetic cocktails. Mayo researchers now report that using the measles virus vector; they’ve trimmed that multi-vector process with four reprogramming factors down to a single […]
View full entry Comment on this
Tags: biomedical research, CCaTS, Dr. Patricia Devaux, Measles Virus, molecular medicine, News Releases, regenerative medicine, stem cells
November 9, 2017
CAR T-Cell Therapy for Relapsed Non-Hodgkin Lymphoma
This story first appeared on the Mayo Clinic News Network. Mayo Clinic announced recently that its Rochester campus is one of 16 cancer centers nationally selected to provide chimeric antigen receptor T-cell therapy (CAR T-cell therapy) for adults with B-cell non-Hodgkin lymphoma who have not responded to, or have relapsed, after two or more lines of treatment. The therapy, […]
Tags: axicabtagene ciloleucel, B-cell non-Hodgkin lymphoma, Dr. Lin, Dr. Yi Lin, Mayo Clinic CAR T-cell therapy, Medical Research, Minnesota News Releases, News Releases, Non-Hodgkin Lymphoma, regenerative immunotherapy, Yescarta, Yi Lin